Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:ALSSFOTCMKTS:ATGSFNASDAQ:CARAOTCMKTS:MARZF On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeALSSFAlsea$2.58+4.0%$2.45$1.89▼$3.50N/AN/A6,403 shs2,365 shsATGSFAutogrill$5.63$5.63$5.63▼$7.46N/AN/A933 shsN/ACARACara Therapeutics$15.19$8.13▼$19.08$24.33M0.4123,145 shs237,144 shsMARZFMarston's$0.58$0.49$0.45▼$0.61N/AN/A1,775 shsN/A10 Stocks Set to Soar in Summer 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceALSSFAlsea0.00%+4.03%-6.18%+26.47%-24.34%ATGSFAutogrill0.00%0.00%0.00%0.00%0.00%CARACara Therapeutics0.00%0.00%0.00%+10.83%+62.99%MARZFMarston's0.00%0.00%+28.44%+28.44%+49.68%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationALSSFAlseaN/AN/AN/AN/AN/AN/AN/AN/AATGSFAutogrillN/AN/AN/AN/AN/AN/AN/AN/ACARACara Therapeutics0.3671 of 5 stars0.00.00.04.20.60.80.0MARZFMarston'sN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceALSSFAlsea 0.00N/AN/AN/AATGSFAutogrill 0.00N/AN/AN/ACARACara Therapeutics 0.00N/AN/AN/AMARZFMarston's 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookALSSFAlseaN/AN/AN/AN/AN/AN/AATGSFAutogrillN/AN/AN/AN/AN/AN/ACARACara Therapeutics$7.14M0.00N/AN/A$12.58 per share0.00MARZFMarston'sN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateALSSFAlseaN/A$1.062.43∞N/AN/AN/AN/A7/21/2025 (Estimated)ATGSFAutogrillN/AN/A0.00∞N/AN/AN/AN/AN/ACARACara Therapeutics-$118.51M-$21.01N/AN/AN/A-1,099.76%-367.97%-107.43%N/AMARZFMarston'sN/A-$0.09N/A∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthALSSFAlseaN/AN/AN/AN/AN/AATGSFAutogrillN/AN/AN/AN/AN/ACARACara TherapeuticsN/AN/AN/AN/AN/AMARZFMarston's$0.0711.21%N/AN/A N/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioALSSFAlseaN/AN/AN/AATGSFAutogrillN/AN/AN/ACARACara TherapeuticsN/A4.774.71MARZFMarston'sN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipALSSFAlsea22.50%ATGSFAutogrillN/ACARACara Therapeutics44.66%MARZFMarston's42.76%Insider OwnershipCompanyInsider OwnershipALSSFAlseaN/AATGSFAutogrillN/ACARACara Therapeutics3.10%MARZFMarston'sN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableALSSFAlsea76,047N/AN/ANot OptionableATGSFAutogrill31,155N/AN/ANot OptionableCARACara Therapeutics804.57 million4.43 millionOptionableMARZFMarston's10,000N/AN/ANot OptionableMARZF, CARA, ALSSF, and ATGSF HeadlinesRecent News About These CompaniesFull Year 2024 Marston's PLC Earnings Presentation TranscriptDecember 3, 2024 | gurufocus.comIs Marston's PLC (LON:MARS) Trading At A 23% Discount?November 20, 2024 | uk.finance.yahoo.comMarston’s toasts sales growth as disposals help it slash debt pileOctober 15, 2024 | standard.co.ukSMarstons Mills, MA Weather ConditionsAugust 25, 2024 | wunderground.comWCheap Flights from St John's to Marston GreenAugust 16, 2024 | skyscanner.netSHeartwood acquire The Woodman from MarstonsAugust 7, 2024 | hospitalityandcateringnews.comHIs Now The Time To Look At Buying Marston's PLC (LON:MARS)?May 21, 2024 | finance.yahoo.comJohn Colin MarstonApril 11, 2024 | csmonitor.comCMarston’s Brewery Saves £60,000 in the First Year with Spirax Sarco Steam TrapsMarch 27, 2024 | just-food.comJMarston's just upgraded at Stifel, here's whyMarch 6, 2024 | realmoney.thestreet.comDowned Wire Closes Marstons Mills RoadFebruary 13, 2024 | msn.comMarston's: A Call Option On The U.K. 'Pub Culture'January 22, 2024 | seekingalpha.comMarstons: Annual Financial ReportDecember 21, 2023 | cbonds.comCMarstons: Directorate ChangeNovember 29, 2023 | cbonds.comCIs Marston's PLC (LON:MARS) Expensive For A Reason? A Look At Its Intrinsic ValueNovember 21, 2023 | finance.yahoo.comDid you make it to the Marstons Brewery darts finalists of 1994?November 7, 2023 | msn.com'Powerful resources.' Marstons Mills cranberry bogs to return to wetlands with $1.6M grantSeptember 21, 2023 | capecodtimes.comCWith 70% ownership of the shares, Marston's PLC (LON:MARS) is heavily dominated by institutional ownersSeptember 20, 2023 | finance.yahoo.comRacehorse shot dead and disposed of on bonfire at home of former jockey and TV hostSeptember 2, 2023 | irishmirror.ieICory MarstonJune 16, 2023 | health.usnews.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeMARZF, CARA, ALSSF, and ATGSF Company DescriptionsAlsea OTCMKTS:ALSSF$2.58 +0.10 (+4.03%) As of 07/2/2025 03:32 PM EasternAlsea, S.A.B. de C.V. operates restaurants in Latin America and Europe. It operates fast food, coffee shops, casual food, and family restaurants under the Domino's Pizza, Starbucks, Burger King, Chili's, PF Chang's, Italianni's, The Cheesecake Factory, Vips, The gate, Foster's Hollywood, Archies, Ginos, T.G.I. Fridays, Vips Europe, Vips Smart, Ole Mole, and Clay Hear brands. The company was incorporated in 1997 and is headquartered in Mexico City, Mexico.Autogrill OTCMKTS:ATGSF$5.63 0.00 (0.00%) As of 03/7/2024Autogrill S.p.A., through its subsidiaries, provides food and beverage services for travelers in North America, Italy, and other European countries. It also sells fuel. The company operates through concessions at airports, motorway rest stops, and railway stations; and in shopping centers, trade fairs, and cultural attractions, as well as on high streets. It manages a portfolio of approximately 300 brands directly or under license. The company was founded in 1947 and is headquartered in Rozzano, Italy. Autogrill S.p.A. is a subsidiary of Dufry AG.Cara Therapeutics NASDAQ:CARACara Therapeutics, Inc., a development-stage biopharmaceutical company, focuses on developing and commercializing therapeutics treatment of chronic pruritus in the United States. The company's lead product is KORSUVA (difelikefalin) injection for the treatment of moderate-to-severe pruritus associated with chronic kidney disease (CKD) in adults undergoing hemodialysis. It also develops Oral difelikefalin, which is in Phase II/III clinical trial to treat chronic pruritus with notalgia paresthetica. The company has license agreements with Maruishi Pharmaceutical Co., Ltd to develop, manufacture, and commercialize drug products containing difelikefalin for acute pain and uremic pruritus in Japan; Vifor Fresenius Medical Care Renal Pharma Ltd. development and commercialization of KORSUVA injection for the treatment of moderate-to-severe pruritus in adult patients undergoing hemodialysis; and Chong Kun Dang Pharmaceutical Corporation to develop, manufacture, and commercialize drug products containing difelikefalin in South Korea. Cara Therapeutics, Inc. was incorporated in 2004 and is based in Stamford, Connecticut.Marston's OTCMKTS:MARZF$0.58 0.00 (0.00%) As of 07/2/2025Marston's PLC operates managed, franchised, tenanted, partnership, and leased pubs in the United Kingdom. It is also involved in the property management; telecommunications; and insurance businesses. The company was formerly known as The Wolverhampton & Dudley Breweries PLC and changed its name to Marston's PLC in January 2007. The company was founded in 1834 and is based in Wolverhampton, the United Kingdom. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas The Apple Comeback Will Be Better Than the Setback Micron’s Big Q3 Drives Applied Materials’ Bullish Outlook Why Occidental's Price Dip Signals a Buying Opportunity Qualcomm’s Hold Rating Misses Strong Growth Story Rigetti Computing: Cantor's Bullish Call May Be Just the Start Insider Selling at NVIDIA Could Turn Into an Opportunity Whiplash for Investors: AeroVironment's Confusing Stock Signals Rocket Lab: Latest Catalysts Bolster the Bull Case Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
